Aberrant microbiota signatures precede symptom development in infantile colic
Journal of Pediatric Gastroenterology and Nutrition · 2025
DOI: 10.1002/jpn3.70101 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Emmy Van Daele und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Wageningen University and Research, Wageningen, the Netherlands. Hauptthemen laut MEDLINE: Colic, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: JPIHDHL.
Abstract (Originalsprache)
Objective
To identify microbial alterations preceding, during, and following infantile colic (IC).
Methods
In the Dutch prospective INCA (INtestinal microbiota Composition after AB treatment in early life) cohort study, 184 term‐born infants were included, of whom 30 had IC. Fecal samples were collected from each infant at eight time points from birth to 2 years and analyzed by 16S rRNA gene amplicon sequencing.
Results
The feces of infants with IC exhibited a significantly different microbiota composition persisting up to 6 months compared to those without IC, characterized by elevated relative abundance of members of the Pseudomonadota and diminished Actinomycetota . Microbial alterations were more pronounced in early‐onset IC (≤4 weeks) than late‐onset IC (≥4 weeks). Late‐onset IC manifested as an early surge in Bacteroides spp. from the first day of life. Streptococcus spp. increased during the crying periods of approximately 30 and 90 days for early‐ and late‐onset IC, respectively. Antibiotic (AB) exposure in the first week was associated with AB‐specific (Days: 2–365) and IC‐dependent (Days: 2–30) genera, with an increase in Enterococcus and a decrease in Bifidobacterium spp.
Conclusions
IC was preceded by a different development of the gut microbiota compared to non‐IC infants, and these differences were more pronounced in early‐onset IC infants. AB exposure in the first week appeared to have specific and overlapping effects on the infants' gut microbiota. These findings may help develop future prevention and treatment approaches for IC. Trial Registration ClinicalTrials.gov identifier: NCT02536560.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology, Wageningen University and Research, Wageningen, the Netherlands.
- Department of Pediatrics, Amsterdam Gastroenterology, Metabolism & Nutrition, Amsterdam Reproduction & Development Amsterdam, Amsterdam UMC Location AMC, Amsterdam, the Netherlands.
- Department of Pediatrics, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands.
- Danone Nutricia Research, Utrecht, the Netherlands.
ORCID-Profile: Arine M Vlieger
Förderung
- JPIHDHL
Zitieren
APA
Daele, E. V., Kamphorst, K., Belzer, C., van Elburg, R. M., Knol, J., Smidt, H., & Vlieger, A. M. (2025). Aberrant microbiota signatures precede symptom development in infantile colic. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70101
Vancouver
Daele EV, Kamphorst K, Belzer C, van Elburg RM, Knol J, Smidt H, et al. Aberrant microbiota signatures precede symptom development in infantile colic. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70101
BibTeX
@article{Daele2025,
author = {Daele, Emmy Van and Kamphorst, Kim and Belzer, Clara and van Elburg, Ruurd M and Knol, Jan and Smidt, Hauke and Vlieger, Arine M},
title = {Aberrant microbiota signatures precede symptom development in infantile colic},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
doi = {10.1002/jpn3.70101}
}
EUVIMED